Skip to main navigation
About
Overview
Leadership
Board of directors
Contact
Science
Programs
THB335
Chronic urticaria
Severe asthma
Clinical Trials
Investors & Media
Overview
Press releases
Events & presentations
Analyst coverage
Governance
SEC filings
Financial results
Annual Report
Careers
Overview
Values
Culture Video
Benefits
Open roles
Annual Reports
2023 Annual Report
6.4 MB
2022 Annual Report
25.6 MB
Print
Contact IR
RSS
Email alerts
